Clinical Trial Update: Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of ulipristal acetate on bleeding patterns and dysmenorrhea in women with adenomyosis; the study status is Withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis
• Dysmenorrhea
• Heavy Uterine Bleeding

Drugs mentioned

• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Adenomyosis, Heavy Uterine Bleeding | Phase 4 | Status: WITHDRAWN